13F HOLDINGS REPORT
GREAT POINT PARTNERS LLC
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0001172661-24-002523
Total Value
$641.6M
Positions
35
Other Managers
2
Confidential Omitted
No
Holdings (35)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | NEUROGENE INC | NGNE | 1,004,291 | $51.1M | 7.97% |
| 2 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 1,128,499 | $44.7M | 6.97% |
| 3 | UROGEN PHARMA LTD | URGN | 2,620,545 | $39.3M | 6.13% |
| 4 | ABIVAX SA | AAVXF | 2,488,483 | $35.6M | 5.55% |
| 5 | EVOLUS INC | EOLS | 2,450,000 | $34.3M | 5.35% |
| 6 | PLIANT THERAPEUTICS INC | PLRX | 1,851,864 | $27.6M | 4.30% |
| 7 | APOGEE THERAPEUTICS INC | APGE | 400,000 | $26.6M | 4.14% |
| 8 | AEROVATE THERAPEUTICS INC | 008064107 | 887,690 | $26.2M | 4.09% |
| 9 | VIRIDIAN THERAPEUTICS INC | VRDN | 1,335,000 | $23.4M | 3.64% |
| 10 | ANAPTYSBIO INC | ANABV | 976,981 | $22.0M | 3.43% |
| 11 | ESPERION THERAPEUTICS INC NE | ESPR | 8,000,000 | $21.4M | 3.34% |
| 12 | INSMED INC | INSM | 775,585 | $21.0M | 3.28% |
| 13 | ARCELLX INC | ACLX | 300,000 | $20.9M | 3.25% |
| 14 | XENON PHARMACEUTICALS INC | XENE | 456,148 | $19.6M | 3.06% |
| 15 | MIND MEDICINE MINDMED INC | 60255C885 | 2,000,000 | $18.8M | 2.93% |
| 16 | DIANTHUS THERAPEUTICS INC | DNTH | 625,000 | $18.8M | 2.92% |
| 17 | OUTLOOK THERAPEUTICS INC | OTLK | 1,480,000 | $17.7M | 2.75% |
| 18 | AMICUS THERAPEUTICS INC | FOLD | 1,495,500 | $17.6M | 2.75% |
| 19 | OCULAR THERAPEUTIX INC | OCUL | 1,728,723 | $15.7M | 2.45% |
| 20 | DYNAVAX TECHNOLOGIES CORP | 268158201 | 1,264,920 | $15.7M | 2.45% |
| 21 | CYTOKINETICS INC | CYTK | 202,202 | $14.2M | 2.21% |
| 22 | OPTINOSE INC | 68404V100 | 8,786,318 | $12.8M | 2.00% |
| 23 | JASPER THERAPEUTICS INC | JSPRW | 407,550 | $12.0M | 1.86% |
| 24 | INTRA-CELLULAR THERAPIES INC | 46116X101 | 150,000 | $10.4M | 1.62% |
| 25 | MERUS N V | N5749R100 | 223,288 | $10.1M | 1.57% |
| 26 | VISTAGEN THERAPEUTICS INC | VTGN | 1,858,735 | $9.8M | 1.53% |
| 27 | TERNS PHARMACEUTICALS INC | TERN | 1,309,975 | $8.6M | 1.34% |
| 28 | IMMUNOCORE HLDGS PLC | IMCR | 115,000 | $7.5M | 1.16% |
| 29 | AUTOLUS THERAPEUTICS PLC | AUTL | 1,166,667 | $7.4M | 1.16% |
| 30 | PUMA BIOTECHNOLOGY INC | PBYI | 1,343,628 | $7.1M | 1.11% |
| 31 | ZURA BIO LTD | ZURA | 2,757,740 | $7.1M | 1.10% |
| 32 | HELIX ACQUISITION CORP II | HLXC | 500,000 | $5.2M | 0.81% |
| 33 | SPYRE THERAPEUTICS INC | SYRE | 125,000 | $4.7M | 0.74% |
| 34 | KYVERNA THERAPEUTICS INC | KYTX | 150,000 | $3.7M | 0.58% |
| 35 | ARVINAS INC | ARVN | 71,113 | $2.9M | 0.46% |